Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes Care

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 10860192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic nephropathy and arterial hypertension

  2004cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM.

  1998cited by this paper
• Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non‐insulin‐dependent diabetes mellitus (NIDDM)

  1998cited by this paper
• Use of Enalapril To Attenuate Decline in Renal Function in Normotensive, Normoalbuminuric Patients with Type 2 Diabetes Mellitus

  1998cited by this paper
• Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.

  1997cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Long-Term Effect of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy

  1997cited by this paper
• Associations of hypertension and complications in non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy.

  1997cited by this paper
• Differences Between Nisoldipine and Lisinopril on Glomerular Filtration Rates and Albuminuria in Hypertensive IDDM Patients With Diabetic Nephropathy During the First Year of Treatment

  1997cited by this paper
• A Meta‐analysis of Trials on Aldose Reductase Inhibitors in Diabetic Peripheral Neuropathy

  1996cited by this paper
• Effect of Risk Factors on Exercise Capacity in NIDDM

  1996cited by this paper
• Effects of Cilazapril and Amlodipine on Kidney Function in Hypertensive NIDDM Patients

  1996cited by this paper
• Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial.

  1996cited by this paper
• Urinary Albumin Excretion as a Predictor of Diabetic Retinopathy, Neuropathy, and Cardiovascular Disease in NIDDM

  1996cited by this paper
• Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.

  1996cited by this paper
• Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).

  1995cited by this paper
• A cohort study of the relationship of diabetic retinopathy to blood pressure.

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• Clinical factors associated with urinary albumin excretion in type II diabetes.

  1995cited by this paper
• The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.

  1994cited by this paper
• Ocular factors in the incidence and progression of diabetic retinopathy.

  1994cited by this paper
• Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients.

  1994cited by this paper
• The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.

  1993cited by this paper
• Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients.

  1993cited by this paper
• Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic Patients

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors.

  1992cited by this paper
• Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients.

  1992cited by this paper
• Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.

  1992cited by this paper
• Appropriate Blood Pressure Control in type II diabetes (ABCD Trial): implications for complications.

  1992cited by this paper
• Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients.

  1992cited by this paper
• The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy.

  1990cited by this paper
• Epidemiological Correlates of Diabetic Neuropathy: Report From Pittsburgh Epidemiology of Diabetes Complications Study

  1989cited by this paper
• Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?

  1989cited by this paper
• Detection, characterization, and staging of polyneuropathy: Assessed in diabetics

  1988cited by this paper
• Incidence of end-stage renal disease in Type 2 (non-insulin-dependent) diabetes mellitus in pima indians

  1988cited by this paper
• Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy

  1988cited by this paper
• High Blood Pressure as Risk Factor in Diabetic Retinopathy Development in NIDDM Patients

  1987cited by this paper
• Prevalence of Diabetic Complications in Relation to Risk Factors

  1986cited by this paper
• Elevated blood pressure and angiotensin II are associated with accelerated loss of renal function in diabetic nephropathy.

  1986cited by this paper
• The Course of Incipient Diabetic Nephropathy: Studies of albumin excretion and blood pressure

  1985cited by this paper
• Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

  1984cited by this paper
• Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians.

  1980cited by this paper
• Role of risk factors in complications of diabetes mellitus.

  1980cited by this paper
• Some aspects of hypertension in diabetes mellitus.

  1967cited by this paper

• Intensive versus routine blood pressure control in patients with type 2 diabetes: a meta-analysis and trial sequential analysis.

  2026cites this paper
• Diabetic retinal disease

  2025cites this paper
• Structure-Function Associations Between Quantitative Contrast Sensitivity Function And Peripapillary Optical Coherence Tomography Angiography in Diabetic Retinopathy

  2025cites this paper
• Preventive and therapeutic strategies via health care delivery system to minimize sight-threatening diabetic retinopathy: a narrative review

  2025cites this paper
• Baseline risk and outcome benefit from intensive blood pressure targeting. A systematic review.

  2025cites this paper
• Intensive Versus Standard Blood Pressure Control in Type 2 Diabetes: Cardiovascular and Microvascular Outcomes.

  2025cites this paper
• Intensive Blood Pressure Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular and Microvascular Outcomes.

  2025cites this paper
• Pharmacotherapy for mild hypertension.

  2025cites this paper
• Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes

  2024cites this paper
• Blood pressure control in diabetic kidney disease: a post-hoc analysis of the FANTASTIC trial

  2024cites this paper
• Chitosan as a promising materials for the construction of nanocarriers for diabetic retinopathy: an updated review

  2024cites this paper
• The lowest well tolerated blood pressure: A personalized target for all?

  2024cites this paper
• Prevalence and risk factors for diabetic retinopathy in Saudi Arabia: systematic review study

  2024cites this paper
• Association between blood pressure control in hypertension and urine sodium to potassium ratio: From the Korea National Health and Nutrition Examination Survey (2016–2021)

  2024cites this paper
• Advancement in Understanding Diabetic Retinopathy: A Comprehensive Review

  2023cites this paper
• The effect of a low renal acid load diet on blood pressure, lipid profile, and blood glucose indices in patients with type 2 diabetes: a randomized clinical trial

  2023cites this paper
• Prevalence and Determinants of Diabetic Retinopathy Among Type 2 Diabetic Patients in Saudi Arabia: A Systematic Review

  2023cites this paper
• Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Death in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

  2023cites this paper
• Blood pressure control for diabetic retinopathy.

  2023cites this paper
• A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

  2023cites this paper
• Association of blood pressure with incident diabetic microvascular complications among diabetic patients: Longitudinal findings from the UK Biobank

  2023cites this paper
• The Associations between Kidney Function and Sexual Dysfunction among Males and Females with Type 2 Diabetes Mellitus

  2023cites this paper
• Associations of diabetic retinopathy severity with high ambulatory blood pressure and suppressed plasma renin levels.

  2023cites this paper
• Long-term effects of blood pressure 130–139/80–89 mmHg on all-cause and cardiovascular mortality among Chinese adults with different glucose metabolism

  2023cites this paper
• Hypertension in diabetes

  2023cites this paper
• Effect of more versus less intensive blood pressure control on cardiovascular, renal and mortality outcomes in people with type 2 diabetes: A systematic review and meta-analysis.

  2023cites this paper
• Diabetic Macular Oedema Guidelines: An Australian Perspective

  2023cites this paper
• Cardiorenal syndrome and diabetes: an evil pairing

  2023cites this paper
• Associations between blood pressure levels and diabetic retinopathy in patients with diabetes mellitus: A population-based study

  2023cites this paper
• The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials

  2022cites this paper
• The Association Between Diabetic Retinopathy and the Prevalence of Age-Related Macular Degeneration—The Kailuan Eye Study

  2022cites this paper
• Hypertension the 'Missed Modifiable Risk Factor' for Diabetic Neuropathy: A Systematic Review.

  2022cites this paper
• Blood Pressure Targets in Adults With Hypertension: A Clinical Practice Guideline From the AAFP.

  2022cites this paper
• Controversies in Hypertension II: the Optimal Target Blood Pressure.

  2022cites this paper
• The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy

  2022cites this paper
• Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021

  2022cites this paper
• Racial Concordance and the Quality of Medical Care: Evidence from the Military

  2022influential citation
• Novel therapies for diabetic retinopathy

  2022cites this paper
• Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?

  2022cites this paper
• Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis.

  2022cites this paper
• Therapeutic Insights in Chronic Kidney Disease Progression

  2021cites this paper
• Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease: A Difficult Equation

  2021cites this paper
• The diastolic blood pressure J-curve revisited: An update

  2021cites this paper
• Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression

  2021cites this paper
• Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus

  2021cites this paper
• Clinical spectrum of diabetic retinopathy and its correlation with risk factors

  2021cites this paper
• Appraisal of Guidelines for the Management of Blood Pressure in Patients with Diabetes Mellitus: The Consensuses, Controversies and Gaps

  2021cites this paper
• Blood pressure targets in adults with hypertension.

  2020cites this paper
• Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy

  2020cites this paper
• Deneysel Diyabetik Nefropatide Patomorfoloji ve Apoptozis

  2020cites this paper
• Approach to Chronic Kidney Disease in the Diabetic Patient

  2020cites this paper
• Short- and long-term treatment with angiotensin-converting enzyme inhibitors or calcium channel blockers for the prevention of diabetic nephropathy progression: A meta-analysis

  2020cites this paper
• Effect of Dietary and Supplemental Lycopene on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

  2020cites this paper
• Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

  2020cites this paper
• 100 most-cited articles on diabetic retinopathy

  2020cites this paper
• Article 3

  2020cites this paper
• Endothelin-1 predicts incident Diabetic Peripheral Neuropathy in Type 2 Diabetes: A cohort study.

  2020cites this paper
• Delineating a role for the Mitochondrial Permeability Transition Pore in Diabetic Kidney Disease by targeting Cyclophilin D.

  2020cites this paper
• Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease

  2020cites this paper
• Hypertension, blood pressure control and diabetic retinopathy in a large population-based study

  2020cites this paper
• Relationship between diabetic retinopathy and diabetic nephropathy; A longitudinal follow-up study from a tertiary care unit of Karachi, Pakistan.

  2020cites this paper
• A54T polymorphism in fatty acid binding protein 2 gene is associated in Type 2 Diabetes Mellitus in adult subjects

  2020cites this paper
• Letter to editor

  2020cites this paper
• Anti-Diabetic Retinopathy Potential of Noni: The beneficial effect and possible mechanism

  2020cites this paper
• Diabetes mellitus type 2 in adults

  2020cites this paper
• Retinopathy among Chinese subjects with type 2 diabetes mellitus in Shanghai: A community-based follow-up study.

  2019cites this paper
• GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials.

  2019influential citation
• Association of High Levels of Spot Urine Protein with High Blood Pressure, Mean Arterial Pressure and Pulse Pressure with the Development of Diabetic Chronic Kidney Dysfunction or Failure among Diabetic Patients. Statistical Regression Modeling to Predict Diabetic Proteinuria

  2019cites this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

  2019cites this paper
• Association Between Early Hypertension Control and Cardiovascular Disease Incidence in Veterans With Diabetes

  2019cites this paper
• Intensive versus Usual Control of Hypertension in the Prevention of Cardiovascular and Renal Outcomes: A Cumulative Meta-Analysis of Randomized Controlled Trials

  2019cites this paper
• A Machine Learning-Based Intelligent System for Predicting Diabetes

  2019cites this paper
• Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysis.

  2019cites this paper
• Diabetes retinopathy and related health management in Asians versus whites using BRFSS 2005-2017 data.

  2019cites this paper
• Optimal blood pressure targets for patients with hypertension: a systematic review and meta-analysis

  2019cites this paper
• Does the benefit from treating to lower blood pressure targets vary with age? A systematic review and meta-analysis.

  2019cites this paper
• Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis

  2019cites this paper
• Cost-Effectiveness of More Intensive Blood Pressure Treatment in Patients with High Risk of Cardiovascular Disease in Saudi Arabia: A Modelling Study of Meta-Analysis

  2019cites this paper
• Quality of Care in Patients with Type 2 Diabetes in Iran: A 5-year retrospective study

  2019cites this paper
• Prevalence of risk factors promoting Diabetic neuropathy .

  2019cites this paper
• Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials : A Meta-Analysis of Treatment Effects of Randomized Controlled Trials

  2019cites this paper
• Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention.

  2019cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• Association Trends Between Antihypertensive Drug Therapies and Diastolic Hypotension in Emirati Patients with Type 2 Diabetes: A Single-Center Retrospective Longitudinal Study

  2018cites this paper
• Hypertension in Adults With Type 2 Diabetes: A Review of Blood Pressure Measurement Methods, Targets and Therapy.

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• Pros and Cons of Intensive Systolic Blood Pressure Lowering

  2018cites this paper
• Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis

  2018cites this paper
• Diabetic Retinopathy in the Asia‐Pacific

  2018cites this paper
• Effects of High Blood Pressure on Cardiovascular Disease Events Among Chinese Adults With Different Glucose Metabolism

  2018cites this paper
• First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.

  2018cites this paper
• Hypertension with diabetes mellitus complications

  2018cites this paper
• Blood pressure targets for hypertension in patients with type 2 diabetes.

  2018cites this paper
• Pharmacological management of hypertension in the elderly and frail populations

  2018cites this paper
• Effect of Modifiable Risk Factors on the Incidence and Progression of Diabetic Retinopathy

  2018cites this paper
• Glycaemic variation in insulin treated diabetic patients with end stage renal disease on maintenance haemodialysis and its effect on cardiac electrical activity

  2018cites this paper
• OBJETIVOS TERAPÉUTICOS EN HIPERTENSIÓN ARTERIAL:METAS DE PRESIÓN ARTERIAL EN LOS DIVERSOS SUBGRUPOS DE HIPERTENSOS

  2018influential citation
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper